Search alternatives:
significant estimates » significant time (Expand Search), significant rates (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
estimates decrease » estimates decreased (Expand Search), estimated decrease (Expand Search), estimated release (Expand Search)
significant estimates » significant time (Expand Search), significant rates (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
estimates decrease » estimates decreased (Expand Search), estimated decrease (Expand Search), estimated release (Expand Search)
-
2321
-
2322
-
2323
-
2324
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2325
-
2326
-
2327
-
2328
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2329
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2330
-
2331
-
2332
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2333
-
2334
-
2335
-
2336
-
2337
-
2338
-
2339
-
2340